The Ultrasonographic Evaluation of Abdominal Accessory Respiratory Muscle Thickness in Patients With Parkinson's Disease: Correlation With Disease Severity and Expiratory Respiratory Muscle Strength
NCT07308795
Summary
Parkinson's disease is a neurodegenerative disorder characterized by both motor and non-motor symptoms. The involvement of respiratory muscles can lead to impairments in respiratory function in these patients. In this study is to evaluate the thickness of abdominal accessory respiratory muscles using ultrasonography in patients with Parkinson's disease. Additionally, the relationship between disease severity and expiratory respiratory muscle strength will be examined. The study will include Parkinson's patients at different stages of the disease, with respiratory muscle thickness measured via ultrasonography. The collected data will then be compared with disease severity and expiratory muscle strength.
Eligibility
Inclusion Criteria: * Age \> 18 years * Parkinson's disease diagnosis with Modified Hoehn and Yahr stages 1-2-3 * Mini-Mental State Examination (MMSE) score \> 23 * Body Mass Index (BMI) \< 30 Exclusion Criteria: * Active smokers * Individuals with a diagnosis of active chest disease * Those with hemodynamic instability * Individuals with unstable vital signs * Parkinson's patients who cannot be controlled with medical treatment * Parkinson Plus syndromes
Conditions5
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07308795